Yongge Liu

Pharmaceutical Product Development (United States)

Also affiliated with Otsuka (United States)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Sputum lipoarabinomannan (LAM) as a biomarker to determine sputum mycobacterial load: exploratory and model-based analyses of integrated data from four cohorts”.

Sputum lipoarabinomannan (LAM) as a biomarker to determine sputum mycobacterial load: exploratory and model-based analyses of integrated data from four cohorts

BMC Infectious Diseases(2022)10.1186/s12879-022-07308-3

N/A

0.727DataRank · unranked

12 citations

Jay Saini, Belinda Kriel, Laura E. Via, Yin Cai, Devon Allies +10 more

Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment

European Respiratory Journal(2022)10.1183/13993003.00166-2022

N/A

0DataRank · unranked

35 citations

Sophia B. Georghiou, Timothy C. Rodwell, Alexei Korobitsyn, Said Abbadi, Kanchan Ajbani +95 more